万泰生物：关于部分募集资金投资项目延期的公告

Core Viewpoint - Wanta Biotech announced the postponement of the "Phase II Expansion Project for the Nine-Valent Cervical Cancer Vaccine" to December 2026, without changing the implementation subject, location, or investment scale [2] Group 1 - The sixth board meeting of Wanta Biotech will be held on December 12, 2025, to review the proposal for the project delay [2] - The proposal does not involve any changes to the use of raised funds and does not require shareholder approval [2]